Latest Conference Articles

Watch as our Executive Vice President for Pharmacy Advocacy discusses pharmacy roles in immunizations, and record his "word of the day" for a chance to win $1000 gift card!

Paul Burton, MD, the Vice President of Janssen Scientific Affairs, LLC, explains the role of pharmacists in diagnosing and treating diabetes with their drug, Invokana (canagliflozin).

In addition to showing no significant imbalance of BKLE amputation, the study also identified a HHF reduction in the general T2D population.

People with T2D have an increased risk of damage to the eyes, kidneys, nerves, legs, heart and brain, and many of these complications can ultimately affect mortality.

Risk factor modification remains key to managing patients with HIV and diabetes.

In this video, Priscilla Hsue, MD, from the University of California San Francisco School of Medicine, explains other health issues patietns with HIV may face as they age.

Kathryn Kreider, DNP, FNP-BC, BC-ADM, explains diabetes associations and the implications it has on health management for patients with diabetes.

Leaders in diabetes research and treatment provide resources to overcome gendered disparities in the field.

A study of another such program—Healthy MOMs, or Mothers on the Move—has shown significant improvements in dietary practices and the incidence of depressive symptoms in Latina mothers at risk for type 2 diabetes.

The top prizes in the global Ascenia Diabetes Challenge were announced Friday at the American Diabetes Association’s 78th Annual Scientific Sessions in Orlando, Florida.

Patients with type 1 diabetes who received a generic vaccine had normal blood sugar levels 8 years later.

This weekly video program provides an inside look at our upcoming American Diabetes Association Scientific Sessions coverage.

Adults with diabetes are 2 to 4 times more likely to have cardiovascular disease, which includes heart disease, heart failure, heart attack and stroke, than people without diabetes

Tracey D. Brown will welcome 16,000 attendees to the premier diabetes health care conference in her first month as chief executive of the American Diabetes Association.

The American Diabetes Association at its 78th Scientific Sessions will recognize 4 physicians who have worked to advance diabetes research and improve patient health outcomes.

Some 13,000 health care professionals from around the world convene each year at this popular meeting to discuss case studies, sympsia, oral presentations, and other forms of new research.

As the 2018 midterm elections approach and the 115th Congress draws to a close, it is important for pharmacists to stay informed on legislative and regulatory issues that have the potential to affect their practice.

In this clip, Mark Neuenschwander, President of The Neuenschwander Company, explains the role that automation and technology plays in health care, and how it will affect the future of pharmacy practice.

In this clip, Mark Neuenschwander, President of The Neuenschwander Company, discussed IV preparation errors and the importance of workflow technologies in reducing error rates.

Patricia C. Kienle, BSPharm, MPA, FASHP, director of accreditation and medication safety at Cardinal Health Innovative Delivery Solutions, discusses the impact of IV drug shortages and the importance of preparing for these shortages.

Fred Massoomi, PharmD, FASHP, Senior Director at Visante, explains how USP 800 regulations will drive the use of closed system transfer devices in health care.

Drug shortages aren’t going away anytime soon, which is why it’s important for pharmacies to put preparedness plans in place ahead of future IV shortages, according to an interactive discussion held this week at the ASHP Summer Meeting and Exhibition.

Leticia Shea, PharmD, BCACP, Associate Professor of Pharmacy at Regis University, discusses why it's important for pharmacists to stay up-to-date on the latest laws and research surrounding medical marijuana use.

Joshua Evans, PhD, assistant professor of health care ethics at Regis University, discusses some of the common ethical dilemmas associated with medical marijuana.

Fred Massoomi, PharmD, FASHP, senior director for Visante, discusses using closed system transfer devices.

In this clip, Fred Massoomi, PharmD, FASHP, Senior Director at Visante, offers advice on the best practices for USP 800 compliance, including gap analysis, individual monitoring, and education.